| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10899733 | Cancer Letters | 2015 | 9 Pages |
Abstract
Our findings suggest that miR-145 functions as a tumor suppressor in ovarian cancer and directly targets HMGA2 oncoprotein. Low miR-145 and high HMGA2 expressions are potential biomarkers of poor prognosis of ovarian carcinoma and miR-145 is the more powerful predictor of patient outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tae Hoen Kim, Ji-ye Song, Hyun Park, Ju-yeon Jeong, A-young Kwon, Jin Hyung Heo, Haeyoun Kang, Gwangil Kim, Hee Jung An,